Our Impact

The Judy and Bernard Briskin Laboratory of the Institute for Myeloma & Bone Cancer Research (IMBCR) has boldly set out to reimagine drug development strategies for multiple myeloma. Working with other centers of excellence and industry leaders from around the world, we have developed novel therapeutic and monitoring approaches.  This is helping to expand treatment options and personalize care for multiple myeloma patients so that they can realize their best outcomes.

Donate Now

Published groundbreaking research from IMBCR has provided the gateway to transformative clinical trials resulting in superior outcomes for patients. This has resulted in an extended life expectancy for myeloma patients – on the average of a decade today and continues to improve!

Read the stories of patients who have been directly impacted by IMBCR research efforts and are LIVING BETTER and LIVING LONGER.

love

John Cook

During an executive physical in 2016, I had an abnormal protein spike. After meeting with their hematologist, I searched, literally the world for the best of the best. I came across IMBCR, a research group dedicated to advancing the treatment of multiple myeloma…

Read More

I then met with Dr Berenson, a clinician who applies this knowledge to his practice.  After looking at the total package, I hands down went with Dr Berenson. His knowledge and enthusiasm are incredible. His people are top notch; the caring and professionalism they have are greatly appreciated.

The first time I met with Dr Berenson I was scared, big time. He helped me relax. Especially knowing they are on my team has a very calming effect.

Today, I don’t really have any pain and the drugs are not messing with my mind. If one drug does not work for you, he will come up with another one. My life has not changed as far as activities, still golf, ski, walk etc.

Dr. Berenson is truly an amazing person. This is what he does. Every time I meet with him, I walk out of there thinking that same thing. I am extremely thankful to Dr Berenson, his team, & the research conducted at IMBCR. I have been a financial supporter to IMBCR since my first visit to their office.


It came out of no-where, I had no symptoms. My hematologist called to see me and informed us that my MGUS had progressed to full blown multiple myeloma – and my life expectancy would be no more than 1-2 years!

Read More
My wife and I started crying and requested a second opinion from the Mayo Clinic, and he instead informed us that there “happened to be” a multiple myeloma specialist (Dr. B.) practicing right here in my back yard. I made immediate contact, squeezed myself in with all my records, and the next day Dr. B. proceeded to soothe us by saying there is plenty of hope and not to panic. Here we are now – 14 amazing years later and going strong! IMBCR research together with Dr. B.’s personal attention, as well as his understanding my needs, have encouraged me to maintain my quality of life during treatment and in my life. This has also allowed me to travel throughout the world.

family

Sidney Teichman


love

Richard Gardiner, MD

I am a physician and have been a competitive and solo athlete all my life. In 2019, I ran over three miles per day. The year 2020 was quite different! Starting in January, I experienced what was initially subtle but rapidly progressive bone pain, tingling nerves, profound weakness, and easy fatiguability. My primary care physician ordered exams and then referred me to a local oncologist, who, in February, told me I had multiple myeloma. He said he would welcome me into his care and later told me I had been “on death’s door.

Read More
However, I am a guy who dots my Is and crosses my Ts, and I always want the best. That evening, I scrutinized the www to find the best care possible. When I saw Dr. Berenson’s website and read what others wrote about him, I realized he would be the perfect fit for me. I knew I was unlikely to receive better care anywhere. I phoned Dr. B’s office that day to see if I could make an appointment. His receptionist, Susan, told me to come in the following day at 6:30 AM. I could hardly believe it. When I got to the office, it was empty except for Dr. B and Susan. Other staff came in later. Dr. B performed a thorough, head-to-toe physical exam and an in-depth interrogation of my life’s story. Then he drilled my iliac bone to extract samples of my bone marrow. He promptly initiated my IV cancer therapy. He gave me a detailed set of instructions, hand-tailored my care to attack my illness and meet my needs, for me to take home. He does not waste time starting personalized, excellent care for his patients. I think of my experience as a nightmare turned into a beautiful dream, and I am alive to tell the tale. By the way, having taken many spills while running, I gave up running in exchange for brisk walking. With ease, I now walk three to five miles every other day. There is no doubt in my mind that my treatment success is related to the groundbreaking work at the IMBCR. Dr. Berenson’s research helps physicians to take better care of their patients worldwide, which makes me feel good. I am alive because of his superb treatment. I tell people, “If I didn’t know I have cancer, I wouldn’t know I was sick.”


To quote the actress Betty Davis, “Getting old is not for sissies”, and I have not been spared to have issues with my health. My diagnosis with multiple myeloma was initially discovered seven years ago when I had a CAT scan looking for something else.

Read More

I was recommended by a world-renowned oncologist to contact Dr. James Berenson to deal with it and I am most grateful for this. For the first five years, the multiple myeloma was smoldering not full blown. The condition worsened, and I was put on a chemo regimen.

Dr. Berenson believes in treatment that lets a patient lead the best life possible. I have been able to continue my ability to travel anywhere my heart or my wife Suzanne desires (though not for the last nine months – due to Covid) and to exercise, play tennis, and do yoga. I have personally been a big supporter of the research conducted at IMBCR. As a result of this research, IMBCR and Dr. Berenson identified a marker that shows if a regimen of drug used in treatment is helping along with a combination of JAK inhibitors with immunomodulatory agents for cancer applications. I have seen these findings benefit Dr. Berenson’s patients directly.

RJCA_beach

Rob D.

Hope, Quality of Life, Love, Living, Passion, Curiosity

The IMBCR Patient Impact

you-have-WHAT

YOU have WHAT?

YOU have WHAT? (the companion book to I Have WHAT?) is now available for purchase. It is a helpful resource for caregivers as well as patients and their families. Caregivers share candid stories about their experiences with Multiple Myeloma, Waldenstrom’s Macroglobulinemia, Amyloidosis, and MGUS (Monoclonal Gammopathy of Undetermined Significance). The book also contains practical advice from healthcare professionals who are experts at caring for these patients.

All proceeds will support IMBCR which is a 501(c)3 organization and tax deductible to the extent permitted by law.

Available for a donation: $45 (price includes cost of book – $40 plus shipping & handling – $5)

Order Now

I have WHAT?

I have WHAT? (the companion book to YOU Have WHAT?) is a helpful resource for patients as well as their families and caregivers. Patients share candid stories about their experiences with Multiple Myeloma, Waldenstrom’s Macroglobulinemia, Amyloidosis, and MGUS (Monoclonal Gammopathy of Undetermined Significance). The book also contains practical advice from healthcare professionals who are experts at caring for these patients.

The third edition features the latest information regarding these diseases and is now available for purchase.

All proceeds will support IMBCR which is a 501(c)3 organization and tax deductible to the extent permitted by law.

Available for a donation: $45 (price includes cost of book – $40 plus shipping & handling – $5)